Loading the map…
Research and experimental development on biotechnology · London
Arkvax
Arkvax Limited
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024* | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
6 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-20
- AccountsTotal exemption full accounts made up to 31 December 2025
- OwnershipChange of details for Dr Jon Cuccui as a person with significant control on 27 December 2023 (and 1 more like it since 13 July 2024)
- OwnershipCessation of Chariot Innovations Limited as a person with significant control on 22 May 2025
- AccountsCurrent accounting period extended from 31 October 2025 to 31 December 2025
- DirectorsDirector's details changed for Dr Jolyon Nicolas Edouard Martin on 1 December 2025
- SharesStatement of capital following an allotment of shares on 22 May 2025 · GBP 1.525305 (and 1 more like it since 7 December 2022)
- DirectorsAppointment of Franciscus Dirven as a director on 18 July 2025
- DirectorsAppointment of Dr Thomas Andrew Weaver as a director on 8 April 2025
- AccountsTotal exemption full accounts made up to 31 October 2024
- FilingResolutions (and 2 more like it since 30 November 2022)
- FilingMemorandum and Articles of Association (and 1 more like it since 30 November 2022)
- SharesChange of share class name or designation (and 1 more like it since 7 December 2022)
14 earlier
- DirectorsTermination of appointment of Nicholas George Stern as a secretary on 30 September 2024
- OwnershipNotification of Chariot Innovations Limited as a person with significant control on 27 December 2023
- AccountsTotal exemption full accounts made up to 31 October 2023
- OwnershipCessation of Brendan William Wren as a person with significant control on 27 December 2023
- DirectorsTermination of appointment of Brendan William Wren as a director on 27 December 2023
- AccountsTotal exemption full accounts made up to 31 October 2022
- DirectorsAppointment of Susan Lee Longhofer as a director on 7 March 2023
- DirectorsAppointment of Dr Jolyon Nicolas Edouard Martin as a director on 20 February 2023
- AddressRegistered office address changed from Moneta Building Babraham Research Campus Cambridge CB22 3AT United Kingdom to London School of Hygiene and Tropical Medicine Keppel Street…
- DirectorsAppointment of Dr Nazira Simin Amra as a director on 29 November 2022
- SharesSub-division of shares on 29 November 2022
- AccountsTotal exemption full accounts made up to 31 October 2021
- DirectorsAppointment of Mr Nicholas George Stern as a secretary on 12 April 2021
- IncorporationIncorporation
- Directors
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Arkvax do?
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
›How much turnover does Arkvax make?
Answered in the full report
›Is Arkvax profitable?
Arkvax's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Arkvax?
Answered in the full report
›Who runs and owns Arkvax?
Answered in the full report
›Where is Arkvax based?
Its registered office is London School Of Hygiene And Tropical Medicine, Keppel Street, London, WC1E 7HT, in London.
›When was Arkvax founded?
Arkvax Limited was incorporated on 22 October 2020.
›Is Arkvax still trading?
The register lists Arkvax Limited as active.